SSPL Securities Private Limited

Monday 16 Jun, 2025 12:27 PM

Omaxe gains on Rs 1,000-cr new Amritsar township launch Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations KBC Global Ltd leads gainers in 'B' group Sterlite Technologies Ltd leads gainers in 'A' group TCS gains on inking multinational deal with Salling Group Spicejet gains as Q4 PAT zooms 173% YoY to Rs 325 cr Lupin inks licensing deal with Sino Universal pharma for Tiotropium DPI drug in China Volumes jump at FDC Ltd counter HBL Engineering rises after securing Rs 133-cr railway contract for Kavach safety system NSE SME Sacheerome hits high notes on debut B R Goyal Infra bags Rs 4-cr work order from NHDC Tata Motors tumbles on weak JLR outlook Sun Pharma appoints Kirti Ganorkar as new MD Sterlite Tech jumps after launching AI-driven data centre solutions Godrej Properties acquires 14-Acre land in East Bengaluru

Saravan Stocks

Company Background


Gland Pharma Ltd	Industry: Pharmaceuticals - Indian - Formulations

BSE Code	ISIN Demat	Book Value(R)	NSE Symbol	Div & Yield %	Market Cap (Rs.Cr)	P/E(TTM)	EPS(TTM)	Face Value(R)
543245	INE068V01023	592.092596	GLAND	1.07	27832.3	25.54	66.14	1

Incorporation Year	1978
Registered Office	Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal, Hyderabad, Telangana-500043
Telephone	91-40-30510999
Fax	91-40-30510800
Chairman	Yiu Kwan Stanley Lau
Managing Director	SRINIVAS SADU
Company Secretary	NA
Auditor	Deloitte Haskins & Sells
Face Value	1
Market Lot	1
Listing	BSE,NSE
Registrar	MUFG Intime India Pvt Ltd C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 41984852

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)